ArticleAtherosclerosis2022

Menopausal hormone therapy and risk of cardiovascular events in women with prediabetes or type 2 diabetes: A pooled analysis of 2917 postmenopausal women.

Yilin Yoshida et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.